Cleared Traditional

K931520 - EPSTEIN-BARR VIRUS VCA (IGM) RECOMB IMMUN ANTIBODY

K931520 is an FDA 510(k) clearance for EPSTEIN-BARR VIRUS VCA (IGM) RECOMB IMM..., manufactured by Mrl Diagnostics. The device is a Class 1 Microbiology device with product code LJN cleared through the Traditional 510(k) pathway after a 396-day FDA review.

K931520 · Mrl Diagnostics · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1994
Decision
396d
Days
Class 1
Risk

K931520 is an FDA 510(k) clearance for the EPSTEIN-BARR VIRUS VCA (IGM) RECOMB IMMUN ANTIBODY. Classified as Antibody Igm, If, Epstein-barr Virus (product code LJN), Class I - General Controls.

Submitted by Mrl Diagnostics (Cypress, US). The FDA issued a Cleared decision on April 26, 1994 after a review of 396 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3235 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Mrl Diagnostics devices

FDA 510(k) Submission Details - K931520

510(k) Number K931520 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 1993
Decision Date April 26, 1994
Days to Decision 396 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
294d slower than avg
Panel avg: 102d · This submission: 396d
Pathway characteristics
Predicate-based equivalence.

LJN Device Classification - Class 1, General Controls

Product Code LJN Antibody Igm, If, Epstein-barr Virus
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3235
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LJN Antibody Igm, If, Epstein-barr Virus

All 16
Devices cleared under the same product code (LJN) and FDA review panel - the closest regulatory comparables to K931520.
SERAQUEST EB VAC IGM
K990977 · Quest Intl., Inc. · Oct 1999
COPALIS EBV-M ANTIBODY ASSAY
K991459 · DiaSorin, Inc. · May 1999
IMMUNOWELL VCA IGM TEST
K973939 · Genbio · Aug 1998
ORTHO*EPSTEIN-BARR VIRUS VCA-IGM ANTIBODY ELISA
K930020 · Ortho Diagnostic Systems, Inc. · Jul 1993
BARTELS EPSTEIN-BARR VIRUS IGM EIA
K922331 · Baxter Diagnostics, Inc. · Sep 1992
EBV IGM ELISA TEST
K910042 · Gull Laboratories, Inc. · Feb 1991